Advertisement

Psychopharmacology

, Volume 168, Issue 1–2, pp 21–30 | Cite as

The validity of the reinstatement model of craving and relapse to drug use

  • Jonathan L. KatzEmail author
  • Stephen T. Higgins
Commentary

Abstract

Rationale

The reinstatement procedure has been used increasingly as a laboratory model of craving and relapse to drug abuse. With the number of reports involving this procedure growing, its validity as a model of relapse merits discussion.

Objectives

The present commentary addresses the validity of the reinstatement procedure in relation to the following three types of models: 1) formal equivalence models, which are assessed on the basis of how well they resemble some phenomenon outside the laboratory (i.e. face validity); 2) correlational models, which are assessed on the basis of how well they predict outcomes of various interventions (such as drug administration or environmental change) when effected outside the laboratory (i.e. predictive validity); and 3) functional equivalence models, which are assessed on the basis of whether the laboratory phenomenon is mechanistically identical or reasonably similar to the phenomenon outside the laboratory (i.e. content validity).

Methods

In order to evaluate the reinstatement model, we briefly examined its various forms and uses, and compared preclinical outcomes to what is known about relapse from the clinical literature.

Results

In its most general form, the reinstatement model has reasonable face validity; that is, there is a general agreement in appearance or form of the behavior in the model and the clinical target, relapse. This face validity is generally absent for the procedure when it is used as a model of craving. The predictive validity of the model has not been established. Evidence from studies of treatments for drug relapse have not supported the validity of the model, however from studies of the effects of the presentation of various types of stimuli (e.g. drug "priming") there is mixed evidence supporting predictive validity. With regard to functional equivalence, there is reasonable evidence supporting functional commonalities between drug self-administration in laboratory animals and human drug abusers, which lends support to the validity of the reinstatement model. However, there are several specific areas of departure between the methods and results using the model and clinical practices and observations about relapse, suggesting a lack of functional equivalence.

Conclusions

There is reasonable evidence to support the face validity of the model, but at this time, neither its predictive validity nor functional equivalence has been fully established, which underscores the need for caution in generalizing results from the model to the clinical condition.

Keywords

Reinstatement Animal models Drug craving Relapse to drug abuse Model validation 

Notes

Acknowledgements

The preparation of this paper was supported by grants from the National Institute on Drug Abuse RO1DA09378 and RO1DA08076 (S.T. Higgins, Principle Investigator), as well as funding by the National Institute on Drug Abuse Intramural Research Program (J.L. Katz, Principle Investigator). J.L.K. thanks Dr. Barry Hoffer for his support. We also thank Dr. Alice Young for comments on an earlier version of the manuscript, Drs. Klaus Miczek and S.S. Negus for stimulating discussions, and Drs. Miczek and Yavin Shaham for inviting our participation in this project.

References

  1. Alvarez LJ, Ramos DL, Flix J, Al-Banchaabouchi M, Menndez R, Pea de Ortiz S, Maldonado-Vlaar CS (2002) Genes encoding proteins within the nucleus accumbens subregions, are affected by reinstatement of cocaine-seeking behavior. Program No. 500.8. 2002 Abstract Viewer/Itinerary Planner. Society for Neuroscience, Washington, D.C., CD-ROMGoogle Scholar
  2. Baker DA, McFarland K, Shen H, Lapish C, Kalivas PW (2002) Cyst(e)ine administration reverses cocaine-induced neuroplasticity in extracellular glutamate levels in the nucleus accumbens and blocks cocaine-induced reinstatement. Program No. 897.8. 2002 Abstract Viewer/Itinerary Planner. Society for Neuroscience, Washington D.C., CD-ROMGoogle Scholar
  3. Barrett JE (1987) Nonpharmacological factors determining the behavioral effects of drugs. In: Meltzer HY (ed) (in association with the American College of Neuropsychopharmacology) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 1493–1501Google Scholar
  4. Bergman J, Katz JL (1998) Behavioral pharmacology of cocaine. In: Higgins ST, Katz JL (eds) Cocaine abuse research: Pharmacology, behavior, and clinical applications. Academic Press, San Diego, pp 51–79Google Scholar
  5. Bergman J, Paronis CA, Gasior M (2002) Concurrent FR 30 schedules of i.v. cocaine and food delivery: effects of dopamine D1 agonists during saline availability. FASEB J 16:A195CrossRefGoogle Scholar
  6. Bowers MS, Lapish CC, Lake RW, McFarland K, Lanier SM, Kalivas PW (2002) AGS3 regulates cocaine seeking and behavioral sensitization following extended withdrawal. Program No. 500.4. 2002 Abstract Viewer/Itinerary Planner. Society for Neuroscience, Washington D.C., CD-ROMGoogle Scholar
  7. Brigham J, Henningfield JE, Stitzer ML (1990–91) Smoking relapse: a review. Int J Addict 25:1239–1255CrossRefPubMedGoogle Scholar
  8. Carlton PL (1978) Theories and models in psychopharmacology. In: Lipton MA, DiMascio A, Killam KF (eds) Psychopharmacology: a generation of progress. Raven Press, New York, pp 553–561Google Scholar
  9. Carlton PL (1983) A primer of behavioral pharmacology: concepts and principles in the behavioral analysis of drug action. Freeman, New York, San FranciscoGoogle Scholar
  10. Chiamulera C, Borgo C, Falchetto S, Valerio E, Tessair M (1996) Nicotine reinstatement of nicotine self-administration after long-term extinction. Psychopharmacology 127:102–107CrossRefPubMedGoogle Scholar
  11. Childress AR, Mozley PD, McElgin W, Fitzgerald J, Reivich M, O'Brien CP (1999) Limbic activation during cue-induced cocaine craving. Am J Psychiatry 156:11–18CrossRefPubMedPubMedCentralGoogle Scholar
  12. Cornish JL, Duffy P, Kalivas PW (1999) A role for nucleus accumbens glutamate transmission in the relapse to cocaine-seeking behavior. Neuroscience 93:1359–1367CrossRefPubMedGoogle Scholar
  13. Cronbach LJ, Meehl PE (1955) Construct validity in psychological tests. Psychol Bull 52:281–302CrossRefPubMedGoogle Scholar
  14. de Wit H (1996) Priming effects with drugs and other reinforcers. Exp Clin Psychopharmacol 4:5–10CrossRefGoogle Scholar
  15. Deneau G, Yanagita T, Seevers MH (1969) Self-administration of psychoactive substances by the monkey. Psychopharmacologia 16:30–48CrossRefPubMedGoogle Scholar
  16. Downs DA, Woods JH (1974) Codeine- and cocaine-reinforced responding in rhesus monkeys: effects of dose on response rates under a fixed-ratio schedule. J Pharmacol Exp Ther 191:179–188PubMedGoogle Scholar
  17. Gilpin EA, Pierce JP, Farkas AJ (1997) Duration of smoking abstinence and success in quitting. J Natl Cancer Inst 89:572–576CrossRefPubMedGoogle Scholar
  18. Gossop M, Green L, Phillips G, Bradley B (1990) Factors predicting outcome among opiate addicts after treatment. Br J Clin Psychol 29:209–216CrossRefPubMedGoogle Scholar
  19. Griffiths RR, Bigelow G, Liebson I (1977) Comparison of social time-out and activity time-out procedures in suppressing ethanol self-administration in alcoholics. Behav Res Ther 15:329–336CrossRefPubMedGoogle Scholar
  20. Griffiths RR, Bigelow GE, Henningfield JE (1980) Similarities in animal and human drug-taking behavior. In: Mello NK (ed) Advances in substance abuse, vol 1. JAI Press, Greenwich, Conn., pp 1–90Google Scholar
  21. Grimm JW, Kruzich PJ, See RE (2000) Contingent access to stimuli associated with cocaine self-administration is required for reinstatement of drug-seeking behavior. Psychobiology 28:383–386Google Scholar
  22. Grimm JW, Hope BT, Wise RA, Shaham Y (2001) Incubation of cocaine craving after withdrawal. Nature 412:141–142CrossRefPubMedPubMedCentralGoogle Scholar
  23. Hall SM, Havassy BE, Wasserman DA (1990) Commitment to abstinence and acute stress in relapse to alcohol, opiates, and nicotine. J Consult Clin Psychol 58:175–181CrossRefPubMedGoogle Scholar
  24. Hall SM, Wasserman DA, Havassy BE, Maude-Griffin P (1998) Relapse to cocaine use. In: Higgins ST, Katz JL (eds) Cocaine abuse research: pharmacology, behavior, and clinical applications. Academic Press, San Diego, pp 389–407Google Scholar
  25. Higgins ST, Badger GJ, Budney AJ (2000) Initial abstinence and success in achieving longer term cocaine abstinence. Exp Clin Psychopharmacol 8:377–386CrossRefPubMedGoogle Scholar
  26. Higgins ST, Alessi SM, Dantona RL (2002) Voucher–based incentives. A substance abuse treatment innovation. Addict Behav 27:887–910CrossRefPubMedGoogle Scholar
  27. Hughes J (2002) Is extinction in animals the same as abstinence in humans? Addiction 97:1219CrossRefPubMedGoogle Scholar
  28. Hunter BE, Walker DW, Riley JN (1974) Dissociation between physical dependence and volitional ethanol consumption: role of multiple withdrawal episodes. Pharmacol Biochem Behav 2:523–529CrossRefPubMedGoogle Scholar
  29. Hutcheson DM, Everitt BJ, Robbins TW, Dickinson A (2001) The role of withdrawal in heroin addiction: enhances reward or promotes avoidance? Nature Neurosci 4:943–948CrossRefPubMedGoogle Scholar
  30. Kenford SL, Smith SS, Wetter DW, Jorenby DE, Fiore MC, Baker TB (2002) Predicting relapse back to smoking: contrasting affective and physical models of dependence. J Consult Clin Psychol 70:216–227CrossRefPubMedGoogle Scholar
  31. Kirby KC, Lamb RJ, Iguchi MY, Husband SD, Platt JJ (1995) Situations occasioning cocaine use and cocaine abstinence strategies. Addiction 90:1241–1252CrossRefPubMedGoogle Scholar
  32. Kosten TR, George TP, Kosten TA (2002) The potential of dopamine agonists in drug addiction. Exp Opin Invest Drugs 11:491–499CrossRefGoogle Scholar
  33. MacCorquodale K, Meehl PE (1948) On a distinction between hypothetical constructs and intervening variables. Psychol Rev 55:95–107CrossRefPubMedGoogle Scholar
  34. Marlatt GA (1996) Models of relapse and relapse prevention: a commentary. Exp Clin Psychopharmacol 4:55–60CrossRefGoogle Scholar
  35. Marlatt GA, Demming B, Reid JB (1973) Loss of control drinking in alcoholics: an experimental analogue. J Abnorm Psychol 81:233–241CrossRefPubMedGoogle Scholar
  36. McFarland K, Ettenberg A (1997) Reinstatement of drug-seeking behavior produced by heroin-predictive environmental stimuli. Psychopharmacology 131:86–92CrossRefPubMedGoogle Scholar
  37. McKay JR, Rutherford, MJ, Alterman, AI, Cacciola JS, Kaplan MR (1995) An examination of the cocaine relapse process. Drug Alcohol Depend 38:35–43CrossRefPubMedGoogle Scholar
  38. McKay JR, Merikle E, Mulvaney FD, Weiss RV, Koppenhaver JM (2001) Factors accounting for cocaine use two years following initiation of care. Addiction 96:213–225CrossRefPubMedGoogle Scholar
  39. McKinney WT (1989) Basis of development of animal models in psychiatry: an overview. In: Koob GF, Ehlers CL, Kupfer DJ (eds) Animal models of depression. Birkhäuser, Boston, Basel, Berlin, pp 3–17Google Scholar
  40. McMillan DE, Katz JL (2002) Continuing implications of the early evidence against the drive-reduction hypothesis of the behavioral effects of drugs. Psychopharmacology 163:251–264CrossRefPubMedGoogle Scholar
  41. Mendelson JH, Mello NK (1996) Management of cocaine abuse and dependence. N Engl J Med 334:965–972CrossRefPubMedGoogle Scholar
  42. Merry J (1966) The "loss of control" myth. Lancet 1:1257–1258CrossRefPubMedGoogle Scholar
  43. Quigley BM, Collins RL (1999) The modeling of alcohol consumption: a meta-analytic review. J Stud Alcohol 60:90–98CrossRefPubMedGoogle Scholar
  44. Reid RL (1957) The role of the reinforcer as a stimulus. Br J Psychol 49:192–200Google Scholar
  45. Robbins SJ, Ehrman RN, Childress AR, O'Brien CP (1999) Comparing levels of cocaine cue reactivity in male and female outpatients. Drug Alcohol Depend 53:223–230CrossRefPubMedGoogle Scholar
  46. Roberts AJ, Heyser CJ, Cole M, Griffin P, Koob GF (2000) Excessive ethanol drinking following a history of dependence: animal model of allostasis. Neuropsychopharmacology 22:581–594CrossRefPubMedGoogle Scholar
  47. Sanger DJ (1991) Screening for abuse and dependence liabilities. In: Willner P (ed) Behavioural models in psychopharmacology: theoretical, industrial and clinical perspectives. Cambridge University Press, Cambridge, New York, Port Chester, Melbourne, Sydney, pp 485–502Google Scholar
  48. Schuster CR, Villarreal JE (1968) The experimental analysis of opioid dependence. In: Efron DH, Cole JO, Levine J, Wittenborn JR (eds) Psychopharmacology, a review of progress 1957–1967, Public Health Service Publication No. 1836, US Government Printing Office, Washington D.C., pp 811–828Google Scholar
  49. Self DW, Nestler EJ (1998) Relapse to drug-seeking: neural and molecular mechanisms. Drug Alcohol Depend 51:49–60CrossRefPubMedGoogle Scholar
  50. Self DW, Barnhart WJ, Lehman DA, Netler EJ (1996) Opposite modulation of cocaine seeking behavior by D1- and D2-like dopamine receptor agonists. Science 271:1586–1589CrossRefPubMedGoogle Scholar
  51. Shaham Y, Miczek KA (2003) Reinstatement—toward a model of relapse. Psychopharmacology DOI 10.1007/s00213-003-1469-zGoogle Scholar
  52. Shaham Y, Stewart J (1995) Stress reinstates heroin self-administration behavior in drug-free animals: an effect mimicking heroin, not withdrawal. Psychopharmacology 119:334–341CrossRefPubMedGoogle Scholar
  53. Shaham Y, Rajabi H, Stewart J (1996) Relapse to heroin-seeking in rats under opioid maintenance: the effects of stress, heroin priming, and withdrawal. J Neurosci 16:1957–1963PubMedGoogle Scholar
  54. Shaham Y, Adamson LK, Grocki S, Corrigall WA (1997) Reinstatement and spontaneous recovery of nicotine seeking in rats. Psychopharmacology 130:396–403CrossRefPubMedGoogle Scholar
  55. Shalev U, Highfield D, Yap J, Shaham Y (2000) Stress and relapse to drug seeking in rats: studies on the generality of the effect. Psychopharmacology 150:337–346CrossRefPubMedGoogle Scholar
  56. Shalev U, Grimm JW, Shaham Y (2002) Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev 54:1–42CrossRefPubMedGoogle Scholar
  57. Skinner BF, Heron WT (1937) Effects of caffeine and benzedrine upon conditioning and extinction. Psychol Rec 1:340–346CrossRefGoogle Scholar
  58. Sobell LC, Sobell MB, Christelman WC (1972) The myth of "one drink." Behav Res Ther 10:119–23CrossRefPubMedGoogle Scholar
  59. Spealman RD, Barrett-Larimore RL, Rowlett JK, Platt DM, Khroyan TV (1999) Pharmacological and environmental determinants of relapse to cocaine-seeking behavior. Pharmacol Biochem Behav 64:327–336CrossRefPubMedGoogle Scholar
  60. Tran-Nguyen TL, Fuchs RA, Coffey GP, O'Dell LE, Baker DA, Neisewander JL (1998) Time-dependent changes in cocaine-seeking behavior and dopamine over-flow in the amygdala during cocaine withdrawal. Neuropsychopharmacology 19:48–59CrossRefPubMedGoogle Scholar
  61. Verhave T (1958) The effect of methamphetamine on operant level and avoidance behavior. J Exp Anal Behav 1:207–220CrossRefPubMedPubMedCentralGoogle Scholar
  62. Walsh SL, Haberny KA, Bigelow GE (2000) Modulation of intravenous cocaine effects by chronic oral cocaine in humans. Psychopharmacology 150:361–373Google Scholar
  63. Wasserman DA, Weinstein MG, Havassy BE, Hall SM (1998) Factors associated with lapses to heroin use during methadone maintenance. Drug Alcohol Depend 52:183–192CrossRefPubMedGoogle Scholar
  64. Willner P (1991) Behavioural models in psychopharmacology. In: Willner P (ed) Behavioural models in psychopharmacology: theoretical, industrial and clinical perspectives. Cambridge University Press, Cambridge, New York, Port Chester, Melbourne, Sydney, pp 3–18Google Scholar
  65. Woods JH, Schuster CR (1971) Opiates as reinforcing stimuli. In: Thompson T, Pickens R (eds) Stimulus properties of drugs. Appleton-Century-Crofts, New York, pp 163–175Google Scholar
  66. Yanagita T, Deneau GA, Seevers MH (1965) Evaluation of pharmacologic agents in the monkey by long-term intravenous self- or programmed administration. Excerpt Med Int Congr Ser 87:453–457Google Scholar

Copyright information

© Springer-Verlag 2003

Authors and Affiliations

  1. 1.Psychobiology Section, NIDA Addiction Research CenterNIH DHHSBaltimoreUSA
  2. 2.Departments of Psychiatry and PsychologyUniversity of VermontBurlingtonUSA

Personalised recommendations